logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11135275 B1

PDFFull Text
Date of Patent:
Oct. 05, 2021

Filed:

Sep. 07, 2018

Coagulation factor-targeting to trem-like transcript 1 (tlt-1) on activated platelets

Applicant:

Novo Nordisk A/s, Bagsvaerd, DK;

Inventors:

Ida Hilden, Frederiksberg, DK;

Bernd Peschke, Slagelse, DK;

Jens Breinholt, Dyssegaerd, DK;

Mikael Kofod-Hansen, Broenshoej, DK;

Assignee:

Novo Nordisk Healthcare AG, Zurich, CH;

Attorney:

Leon Y. Lum

Primary Examiner:

Sheridan Swope

Int. Cl.
CPC ...
A61K 38/48 (2006.01); A61K 47/68 (2017.01); C07K 16/28 (2006.01); C07K 14/47 (2006.01); C12N 9/64 (2006.01); C07K 14/745 (2006.01); C12N 9/96 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4846 (2013.01); A61K 47/6815 (2017.08); A61K 47/6849 (2017.08); C07K 14/4703 (2013.01); C07K 14/745 (2013.01); C07K 16/2803 (2013.01); C12N 9/644 (2013.01); C12N 9/6437 (2013.01); C12N 9/96 (2013.01); C12Y 304/21021 (2013.01); C12Y 304/21022 (2013.01); A61K 38/00 (2013.01); C07K 2299/00 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/41 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/92 (2013.01); C07K 2319/00 (2013.01); C07K 2319/21 (2013.01);
Abstract

Described are procoagulant proteins which may, for example, be fusion proteins or chemical conjugates; methods of producing procoagulant proteins; polynucleotides that encode fusion proteins and cells that expresses them. Furthermore, described are procoagulant proteins for use as a medicament. Individuals that have a coagulopathy, such as haemophilia A and B with or without inhibitors, may be treated with such procoagulant proteins.

Find Patent Forward Citations

Hilden, Ida. (2021). Coagulation factor-targeting to trem-like transcript 1 (tlt-1) on activated platelets (U.S. Patent No. 11135275). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11135275

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…